Component
Strontium deposition in newly formed human bone
Context-specific entity; species, compartment and exposure are stated on each claim.
2 recorded relationships. Experimental role, claim status and evidence remain attached to each record.
How nutrients influence it
Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.
Other things that act on it
Enzymes, hormones, genes, and other components with a recorded effect. These are not nutrients, so they do not count toward the arrows above. Each finding names the chapter that recorded it.
How nutrients reach it in more than one step
Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.
Tracing routes…
What it does
Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.
What acts on it
Biopsies from ranelate-treated osteoporotic women localized strontium mainly to bone structural units formed during treatment, with old units reported devoid of strontium in the analyzed samples.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Human treatment biopsies; X-ray microanalysis and cartography, up to three years for these analyses.
- limitations
- Sampled iliac bone does not define uptake or release kinetics for the entire skeleton.
- nutrient_topic
- Strontium collection; molecular form, preparation, species, exposure and manipulation remain explicit. · Strontium
- plain_language
- Bone turnover determines where the element is incorporated.
- primary_references
- In osteoporotic women treated with strontium ranelate, strontium is located in bone formed during treatment with a maintained degree of mineralization. · 2010 · https://pubmed.ncbi.nlm.nih.gov/19597910/ · DOI 10.1007/s00198-009-1005-z
Strontium: calcium interactions, cellular mechanisms and mineralization (2026-09-19) · lines 294–300
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Human treatment biopsies; X-ray microanalysis and cartography, up to three years for these analyses. · source_derived_draft · unverified_draft
## strontium-bone-localization Bone turnover determines where the element is incorporated. Biopsies from ranelate-treated osteoporotic women localized strontium mainly to bone structural units formed during treatment, with old units reported devoid of strontium in the analyzed samples. Model: Human treatment biopsies; X-ray microanalysis and cartography, up to three years for these analyses. Limitations: Sampled iliac bone does not define uptake or release kinetics for the entire skeleton. Evidence access: Primary abstract In osteoporotic women treated with strontium ranelate, strontium is located in bone formed during treatment with a maintained degree of mineralization. · 2010 · https://pubmed.ncbi.nlm.nih.gov/19597910/ · DOI 10.1007/s00198-009-1005-z
Complete structured claim and evidence
Where it participates (unsigned role)
Across 34 iliac biopsies after 2–60 months of ranelate treatment, secondary mineralization remained at a normal level while the bone area containing strontium increased.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Human iliac-bone microradiography and microanalysis.
- limitations
- Related clinical research program; not independent randomized proof of every cellular mechanism or absence of all adverse effects.
- nutrient_topic
- Strontium collection; molecular form, preparation, species, exposure and manipulation remain explicit. · Strontium
- plain_language
- A human biopsy series did not reproduce generalized mineralization failure.
- primary_references
- Distribution of strontium and mineralization in iliac bone biopsies from osteoporotic women treated long-term with strontium ranelate. · 2011 · https://pubmed.ncbi.nlm.nih.gov/21690207/ · DOI 10.1530/EJE-11-0415
Strontium: calcium interactions, cellular mechanisms and mineralization (2026-09-19) · lines 302–308
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Human iliac-bone microradiography and microanalysis. · source_derived_draft · unverified_draft
## strontium-biopsy-mineralization A human biopsy series did not reproduce generalized mineralization failure. Across 34 iliac biopsies after 2–60 months of ranelate treatment, secondary mineralization remained at a normal level while the bone area containing strontium increased. Model: Human iliac-bone microradiography and microanalysis. Limitations: Related clinical research program; not independent randomized proof of every cellular mechanism or absence of all adverse effects. Evidence access: Primary abstract Distribution of strontium and mineralization in iliac bone biopsies from osteoporotic women treated long-term with strontium ranelate. · 2011 · https://pubmed.ncbi.nlm.nih.gov/21690207/ · DOI 10.1530/EJE-11-0415
Complete structured claim and evidence
The events it takes part in
A mechanism often involves more than two components. These are the full events, with every participant and its role.
Situations it appears in
Low-supply and faulty-machinery situations recorded in the chapters where this component plays a part.
In the sources
Preserved passages that mention this component, quoted exactly. Open one to read it in context.
Open hypotheses
Proposed ideas that involve this component. They are labeled as hypotheses and do not change any recorded statement.
This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.